CDKN2A/P16-INK4A Rekombinanter Antikörper

CDKN2A/P16-INK4A Rekombinant Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

241438B2

Kat-Nr. : 81373-10-PBS

Synonyme

P16, p16 INK4, P16 INK4A, p16INK4A, P16-INK4A



Geprüfte Anwendungen

Produktinformation

81373-10-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA CDKN2A/P16-INK4A und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen CDKN2A/P16-INK4A fusion protein Ag1328
Vollständiger Name cyclin-dependent kinase inhibitor 2A
Berechnetes Molekulargewicht 16 kDa
Beobachtetes Molekulargewicht 16 kDa
GenBank-ZugangsnummerBC021998
Gene symbol CDKN2A
Gene ID (NCBI) 1029
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

P16-INK4A is also named as CDKN2A, MLM, Tumor suppressor ARF, Alternative reading frame. The tumor suppressor protein p16Ink4a (encoded from the CDKN2A locus) is often transcriptionally activated in cells undergoing senescence and is one of the main regulators of this program, and it is upregulated in multiple tissues during aging (PMID:17055429). p16-Ink4a is the principal member of the Ink4 family of CDK inhibitors. p16-Ink4a contributes to the regulation of cell cycle progression by inhibiting the S phase. p16Ink4a binds to CDK4/6, inhibiting cyclin D-CDK4/6 complex formation and CDK4/6-mediated phosphorylation of Rb family members. Expression of p16-Ink4a maintains the Rb family members in a hypophosphorylated state, which promotes binding to E2F1 and leads to G1 cell cycle arrest (PMID: 21297668).